Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
2.510
+0.170 (7.26%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Context Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Cash & Equivalents | 66 | 94.43 | 14.45 | 35.5 | 49.64 | Upgrade
|
| Cash & Short-Term Investments | 66 | 94.43 | 14.45 | 35.5 | 49.64 | Upgrade
|
| Cash Growth | -30.11% | 553.50% | -59.29% | -28.48% | 16976.13% | Upgrade
|
| Prepaid Expenses | 2.16 | 3.27 | 1.6 | 2.36 | 1.62 | Upgrade
|
| Other Current Assets | 0.2 | 0.2 | - | - | - | Upgrade
|
| Total Current Assets | 68.35 | 97.9 | 16.05 | 37.85 | 51.26 | Upgrade
|
| Property, Plant & Equipment | 0.14 | 0.23 | 0.02 | 0.08 | - | Upgrade
|
| Other Long-Term Assets | - | - | - | 0.03 | 0.05 | Upgrade
|
| Total Assets | 68.49 | 98.13 | 16.06 | 37.97 | 51.31 | Upgrade
|
| Accounts Payable | 2.53 | 1.45 | 2.38 | 0.94 | 1.83 | Upgrade
|
| Accrued Expenses | 5.34 | 1.14 | 1.8 | 2.13 | 1.12 | Upgrade
|
| Current Portion of Leases | 0.11 | 0.11 | - | 0.06 | - | Upgrade
|
| Other Current Liabilities | 0.04 | 0.05 | 0.01 | 0.08 | 0.09 | Upgrade
|
| Total Current Liabilities | 8.02 | 2.75 | 4.19 | 3.21 | 3.03 | Upgrade
|
| Long-Term Leases | - | 0.11 | - | - | - | Upgrade
|
| Total Liabilities | 8.02 | 2.86 | 4.19 | 3.21 | 3.03 | Upgrade
|
| Common Stock | 0.09 | 0.09 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 191.29 | 189.96 | 79.91 | 78.83 | 77.51 | Upgrade
|
| Retained Earnings | -130.9 | -94.78 | -68.05 | -44.09 | -29.25 | Upgrade
|
| Total Common Equity | 60.47 | 95.27 | 11.87 | 34.76 | 48.27 | Upgrade
|
| Shareholders' Equity | 60.47 | 95.27 | 11.87 | 34.76 | 48.27 | Upgrade
|
| Total Liabilities & Equity | 68.49 | 98.13 | 16.06 | 37.97 | 51.31 | Upgrade
|
| Total Debt | 0.11 | 0.22 | - | 0.06 | - | Upgrade
|
| Net Cash (Debt) | 65.88 | 94.21 | 14.45 | 35.44 | 49.64 | Upgrade
|
| Net Cash Growth | -30.07% | 551.98% | -59.23% | -28.59% | - | Upgrade
|
| Net Cash Per Share | 0.69 | 1.61 | 0.91 | 2.22 | 17.52 | Upgrade
|
| Filing Date Shares Outstanding | 91.88 | 89.7 | 15.97 | 15.97 | 15.97 | Upgrade
|
| Total Common Shares Outstanding | 91.88 | 89.7 | 15.97 | 15.97 | 15.97 | Upgrade
|
| Working Capital | 60.33 | 95.15 | 11.86 | 34.65 | 48.22 | Upgrade
|
| Book Value Per Share | 0.66 | 1.06 | 0.74 | 2.18 | 3.02 | Upgrade
|
| Tangible Book Value | 60.47 | 95.27 | 11.87 | 34.76 | 48.27 | Upgrade
|
| Tangible Book Value Per Share | 0.66 | 1.06 | 0.74 | 2.18 | 3.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.